Status:
COMPLETED
Electrical Impedance Myography and Ultrasound as Biomarkers of Duchenne Muscular Dystrophy
Lead Sponsor:
Boston Children's Hospital
Collaborating Sponsors:
Beth Israel Deaconess Medical Center
Conditions:
Duchenne Muscular Dystrophy
Eligibility:
MALE
2-30 years
Brief Summary
Researchers at Children's Hospital Boston Neurology Department invite children to participate in a new research study. Researchers are looking for boys ages 2 - 30 with Duchenne Muscular Dystrophy (DM...
Detailed Description
Characterized by progressive disability leading to death, Duchenne muscular dystrophy (DMD) remains one of the most common and devastating neuromuscular disorders of childhood. Although a variety of p...
Eligibility Criteria
Inclusion
- Inclusion criteria (DMD):
- Genetically or histologically established diagnosis of DMD
- Male, age 2 - 30
- Inclusion criteria (Control):
- 1\. Male, age 2 - 30
- Exclusion criteria (DMD):
- Presence of implanted pacemaker or other electrical device
- Presence of a superimposed neuromuscular or other medical condition that substantially impacts the individual's health
- Exclusion criteria (control):
- Presence or past history of a neuromuscular disorder or other disease that substantially impacts health
- Presence of implanted pacemaker or other electrical device.
Exclusion
Key Trial Info
Start Date :
April 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2015
Estimated Enrollment :
73 Patients enrolled
Trial Details
Trial ID
NCT01491555
Start Date
April 1 2012
End Date
September 1 2015
Last Update
March 24 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Hospital Boston
Boston, Massachusetts, United States, 02115